Zobrazeno 31 - 40
of 443
pro vyhledávání: '"Steven M. Devine"'
Autor:
Jen L. Novakovich, Sade T. Fridy-Chesser, Steven M. Devine, Jeni Newman, Karl Hailperin, Gretta Stritesky, Jeffery J. Auletta
Publikováno v:
Transplantation and Cellular Therapy
Highlights • The National Marrow Donor Program (NMDP) received preliminary search requests for over 3300 domestic and 3700 international allogeneic hematopoietic cell transplant candidates during the initial phase of the coronavirus disease 2019 (C
Autor:
Richard J. Jones, Andrew R. Rezvani, Lawrence E. Morris, Peter Dawson, Joseph P. McGuirk, Eric S. Leifer, John M. Magenau, Paul O'Donnell, Chatchada Karanes, Steven M. Devine, Ephraim J. Fuchs, Mary M. Horowitz, Mary Eapen, Joseph H. Antin, Claudio G. Brunstein, Mitchell E. Horwitz, Brent R. Logan
Publikováno v:
Blood. 137:420-428
Results of two parallel phase II trials of transplantation of unrelated umbilical cord blood or bone marrow from HLA-haploidentical relatives provided equipoise for direct comparison of these donor sources. Between June 2012 and June 2018, 368 patien
Autor:
Yoshihiro Inamoto, Michael R. Grunwald, Stefan O. Ciurea, Bhagirathbhai Dholaria, Cesar Rodriguez, Tania Jain, Miguel-Angel Perales, Betul Oran, Betty K. Hamilton, Firas El Chaer, Navneet S. Majhail, Martin S. Tallman, Mahmoud Aljurf, Mohamed A. Kharfan-Dabaja, Bipin N. Savani, Hien D. Liu, Arnon Nagler, Gabriel N. Mannis, Mehdi Hamadani, Zachariah DeFilipp, Gordon L. Phillips, Nina Shah, Shahrukh K. Hashmi, Paul A. Carpenter, Al Fadel AlShaibani, Frederick R. Appelbaum, Noa G. Holtzman, Steven M. Devine, Mohamad Mohty
Publikováno v:
Transplantation and Cellular Therapy. 27:6-20
The role of hematopoietic cell transplantation (HCT) in the management of newly diagnosed adult acute myeloid leukemia (AML) is reviewed and critically evaluated in this evidence-based review. An AML expert panel, consisting of both transplant and no
Autor:
Monzr M. Al Malki, Brian C. Shaffer, Steven M. Devine, Bronwen E. Shaw, Larisa Broglie, Muna Qayed, Sung Won Choi, Stephen Spellman, Craig Malmberg, Eric Ndifon, Brent Logan, Jeffery James Auletta, Heather E. Stefanski, Janelle Olson, Antonio Jimenez Jimenez
Publikováno v:
Transplantation and Cellular Therapy. 29:S236
Autor:
Rachel Phelan, Min Chen, Caitrin Bupp, Yung-Tsi Bolon, Larisa Broglie, Janet Brunner-Grady, Linda J. Burns, Saurabh Chhabra, Debra Christianson, Rachel Cusatis, Steven M. Devine, Anita D'Souza, Mary Eapen, Mehdi Hamadani, Mary Hengen, Stephanie J. Lee, Amy Moskop, Kristin M. Page, Marcelo Pasquini, Waleska S. Pérez, Marcie Riches, Doug Rizzo, Wael Saber, Stephen R. Spellman, Heather E. Stefanski, Patricia Steinert, Daniel Weisdorf, Mary Horowitz, Jeffery J. Auletta, Bronwen E. Shaw, Mukta Arora
Publikováno v:
Transplant Cell Ther
Hematopoietic cell transplantation (HCT) has been successfully utilized as treatment for many malignant and non-malignant conditions. As supportive care, donor selection, and treatment modalities evolve, documenting HCT trends and outcomes is critica
Autor:
Akshata, Pandit, Lai, Wei, Luis, Bustamante, Patrick, Elder, William B S, Falk, Megan, Sell, Ashley, Rosko, Don M, Benson, Steven M, Devine, Craig C, Hofmeister, Yvonne A, Efebera
Publikováno v:
Arch Hematol Blood Dis
To date, there is no standard of care for patients with newly diagnosed Primary (AL) amyloidosis. Autologous hematopoietic stem cell transplant (aHSCT) is a reasonable option, but has been limited in its use due to increase in treatment-related morta
Autor:
Derek Schatz, Jonathan A. Gutman, Daniel A. Pollyea, Natalie Monson, Andrew Kent, Steven M. Devine, Clayton A. Smith, Sumithira Vasu
Publikováno v:
Blood Adv
Key Points Posttransplantation, glasdegib maintenance therapy in patients at high risk for relapse did not meaningfully reduce relapse incidence. Use of glasdegib in the posttransplantation setting was complicated by adverse events requiring drug hol
Autor:
Marcelo C. Pasquini, Mary M. Horowitz, Bronwen E. Shaw, Saurabh Chhabra, Xiao Ying Tang, Wael Saber, Daniel J. Weisdorf, Hai-Lin Wang, Mary Eapen, Anita D'Souza, Kyle Hebert, Mukta Arora, Steven M. Devine, Rachel Phelan, Stephanie J. Lee, J. Douglas Rizzo, Mingwei Fei, Mei-Jie Zhang, Mehdi Hamadani
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:e161-e166
With the COVID-19 pandemic and the ensuing barriers to the collection and transport of donor cells, it is often necessary to collect and cryopreserve grafts before initiation of transplantation conditioning. The effect on transplantation outcomes in
Autor:
Mohamad Aghaie Meybodi, Mehdi Hamadani, Marcelo C. Pasquini, Armin Rashidi, Steven M. Devine, Erica D. Warlick, Haitao Chu, Wenhao Cao, Daniel J. Weisdorf
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:e138-e141
In a systematic review and meta-analysis, we compared allogeneic transplant outcomes after myeloablative conditioning (MAC) versus reduced-intensity conditioning (RIC) in patients with myelodysplastic syndromes. Only 2 published randomized clinical t
Autor:
Kami J. Maddocks, Beth Christian, Amelia Langston, Mary Jo Lechowicz, Lai Wei, Steven M. Devine, Kristie A. Blum, Leonard T. Heffner, Christopher R. Flowers, Pierluigi Porcu, Jonathon B. Cohen
Publikováno v:
Cancer. 126:1235-1242
Background Both gemcitabine and bendamustine have been evaluated in patients with recurrent/refractory Hodgkin lymphoma but to the authors' knowledge not as a doublet. The authors completed a phase 1/2 trial to identify the optimal dose and frequency